• Most Popular
  • Most Shared

Zeltia's Yondelis gets approval in Philippines

Fri Jul 10, 2009 2:44am EDT

Stocks

   

MADRID, July 10 (Reuters) - Spain's Zeltia (ZEL.MC) said on Friday its Yondelis drug had been approved for the treatment of recurrent ovarian cancer in The Philippines.

Stocks  |  Global Markets

It marked the first approval of its kind for the company in the treatment of this disease, Zeltia said.

Yondelis, made by Zeltia's Pharma Mar unit, was also given the green light for the treatment of advanced soft tissue sarcoma in adults, it said. (Reporting by Elisabeth O'Leary; Editing by Andrew Hay)

Stocks
Global Markets


More from Reuters

Photo

New security restrictions could hurt airlines

NEW YORK (Reuters) - Tighter security measures at U.S. airports following an attempt to blow up a Detroit-bound jet could dampen enthusiasm for air travel, hurting the airline industry just as it seemed poised to recover from a period of bruising losses, some industry experts say.

» More Top News
A Delta Airbus 330 airliner sits on a runway at Detroit Metropolitan Airport in Romulus, Michigan in this video grab made December 25, 2009. Credit: REUTERS/WDIV TV/Handout

The battle in mid-air

The attraction of bombing airliners means the aviation industry has to be constantly vigilant in its fight against attackers.  Full Article 

U.S.
A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
Political Risk in 2010:

Don't say we didn't warn you

With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

Global Markets